Myosin-9 (MYH9 or DFNA17) Antibody
Description
Anti-Myosin-9 (MYH9 or DFNA17) antibody is validated on mouse tissue and recommended for immunofluorescence labeling, IHC, or western blot of materials from rodent and human tissues. Myosin-9 also known as myosin, heavy chain 9, non-muscle or non-muscle myosin heavy chain IIa (NMMHC-IIA), is a myosin protein that is encoded by the MYH9 gene in human. Myosin-9 is expressed in most cells and tissues where it participates in a variety of processes requiring contractile force, such as cytokinesis, cell migration, polarization and adhesion, maintenance of cell shape, and signal transduction. Defects in this gene have been associated with non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness.
Application: | Immunofluorescence, Immunohistochemistry, Western Blot |
---|---|
Clonality: | Polyclonal |
Concentration: | 0.25 mg/ml |
Conjugation: | Unconjugated |
Host: | Rat |
Immunogen: | Synthetic peptide (19-aa) derived from the N-terminal region of human Myosin-9 protein |
Isotype: | IgG |
Purification: | Affinity Chromatography |
Reactivity: | Human, Mouse, Rat |
Species Homology: | Synthetic peptide sequence is identical to mouse or rat sequence |
Storage: | -20°C |
Storage Buffer: | PBS, pH 7.2, 0.1% Sodium Azide |